Egis Pharma Services

Egis is a Hungarian pharmaceutical company with an impressive history, which has developed from a small factory producing nutriments in Kőbánya (Budapest) to one of the leading generic pharmaceutical companies in Eastern and Central Europe in more than 110 years.

Egis’ products are manufactured at its three production sites in Hungary:  active ingredient manufacturing plants are located at its headquarters at Keresztúri Street (Budapest), its tabletting, injection, and packaging plants along with one of its warehouses for finished products are based at the production site at Bökényföldi Street (Budapest). At Egis’ production site in the town of Körmend tablets, dragées and pellets are produced in the tabletting plant, while in the galenic plant ointments, suppositories, solutions, syrups, and aerosols are manufactured.

Besides Hungary, Egis sells its products under Egis’ brand names in 17 countries.  In total, the company’s APIs and finished products are available in 103 countries through the network of Egis subsidiaries and representative offices or partners. The company’s portfolio consists of 642 products that belong to 166 product lines and contain 149 active ingredients. Egis’ focus lies on treating diseases of the cardiovascular and central nervous systems; however, it also provides modern treatment solutions in the fields of diabetology, dermatology and wound care.

Egis' activities incorporate all areas of the generic pharmaceutical value chain: from R&D through the production of APIs and FPs to sales and marketing.

New activity in the portfolio of Egis Pharmaceuticals PLC: contract development and manufacturing

At Egis, the roots of active pharmaceutical ingredient development and manufacturing date back to the 1920s, and our experts have special experience in this field. We make it sure that the knowledge gathered over the decades is passed on and the high level of competence of our specialists, complemented by state-of-the-art technological equipment, ensures innovative and efficient solutions while meeting the highest quality standards.

From 2023, Egis offers a wide range of small molecule drug substance and intermediate development and manufacturing services to pharmaceutical partners.

Egis Pharma Services - Contact us!
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox